• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Apr 13;15(1):3210.
doi: 10.1038/s41467-024-47590-0. Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children

Janice Z Jia[SUP] #[/SUP][SUP] 1 [/SUP], Carolyn A Cohen[SUP] #[/SUP][SUP] 1 [/SUP], Haogao Gu[SUP] #[/SUP][SUP] 2 [/SUP], Milla R McLean[SUP] 3 [/SUP], Raghavan Varadarajan[SUP] 4 [/SUP], Nisha Bhandari[SUP] 4 [/SUP], Malik Peiris[SUP] 2 5 [/SUP], Gabriel M Leung[SUP] 6 7 [/SUP], Leo L M Poon[SUP] 1 2 5 [/SUP], Tim Tsang[SUP] 6 [/SUP], Amy W Chung[SUP] 3 [/SUP], Benjamin J Cowling[SUP] 6 [/SUP], Nancy H L Leung[SUP] 6 [/SUP], Sophie A Valkenburg[SUP] 8 9 [/SUP]



Affiliations
Abstract

Cross-reactive antibodies with Fc receptor (FcR) effector functions may mitigate pandemic virus impact in the absence of neutralizing antibodies. In this exploratory study, we use serum from a randomized placebo-controlled trial of seasonal trivalent influenza vaccination in children (NCT00792051) conducted at the onset of the 2009 H1N1 pandemic (pH1N1) and monitored for infection. We found that seasonal vaccination increases pH1N1 specific antibodies and FcR effector functions. Furthermore, prospective baseline antibody profiles after seasonal vaccination, prior to pH1N1 infection, show that unvaccinated uninfected children have elevated ADCC effector function, FcγR3a and FcγR2a binding antibodies to multiple pH1N1 proteins, past seasonal and avian (H5, H7 and H9) strains. Whereas, children that became pH1N1 infected after seasonal vaccination have antibodies focussed to seasonal strains without FcR functions, and greater aggregated HA-specific profiles for IgM and IgG3. Modeling to predict infection susceptibility, ranked baseline hemagglutination antibody inhibition as the highest contributor to lack of pH1N1 infection, in combination with features that include pH1-IgG1, H1-stem responses and FcR binding to seasonal vaccine and pH1 proteins. Thus, seasonal vaccination can have benefits against pandemic influenza viruses, and some children already have broadly reactive antibodies with Fc potential without vaccination and may be considered 'elite influenza controllers'.


 
Back
Top Bottom